We have located links that may give you full text access.
Nicotinamide Riboside Preserves Ovarian Injury in Experimental Sepsis Model in Rats.
Eurasian Journal of Medicine 2023 January 18
OBJECTIVES: The aim of the study is to investigate the protective effects of nicotinamide riboside on oxidative stress in an experimental sepsis model created by cecal ligation and puncture (CLP).
MATERIALS AND METHODS: Rats were divided into 3 groups randomly: Sham operated (control) group, sepsis (CLP+Saline) group and nicotinamide riboside -treated (CLP+NR) group. Sepsis model induced cecal ligation and puncture (CLP) was applied in CLP+Saline group rats. Animals in the CLP+NR group were administered intraperitoneally nicotinamide riboside (500 mg/kg). Tissue specimens of rats were biocemically calculated activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO) and malondialdehyde (MDA) levels. Ovarian tissues of all rats were histopathologically evaluated.
RESULTS: CAT, SOD and GSH-Px activities were lower in the sepsis group as compared to the sham operated (control) group. In nicotinamide riboside -treated (CLP+NR) group SOD activity were significantly increased than control and sepsis (CLP+Saline) group (P<0.05). In CLP+ NR group, MPO activities and mean MDA concentration of ovarian tissue were lower than in CLP+Saline group (P<0.05). The light microscopic assesment revealed that ovarian tissue was protected, and inflammation and interstitial edema decreased in CLP+ NR group. The follicular damage findings were notably decreased in CLP+NR group in comparison with CLP+Saline group (P<0.05).
CONCLUSIONS: Our findings indicated that nicotinamide riboside diminished ovarian injury in sepsis via inhibition of tissue infiltration and incresing of endogenous antioxidant capacity. Nicotinamide Riboside administration may represent a new treatment approache for the prevention of sepsis induced ovarian injury.
MATERIALS AND METHODS: Rats were divided into 3 groups randomly: Sham operated (control) group, sepsis (CLP+Saline) group and nicotinamide riboside -treated (CLP+NR) group. Sepsis model induced cecal ligation and puncture (CLP) was applied in CLP+Saline group rats. Animals in the CLP+NR group were administered intraperitoneally nicotinamide riboside (500 mg/kg). Tissue specimens of rats were biocemically calculated activities of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO) and malondialdehyde (MDA) levels. Ovarian tissues of all rats were histopathologically evaluated.
RESULTS: CAT, SOD and GSH-Px activities were lower in the sepsis group as compared to the sham operated (control) group. In nicotinamide riboside -treated (CLP+NR) group SOD activity were significantly increased than control and sepsis (CLP+Saline) group (P<0.05). In CLP+ NR group, MPO activities and mean MDA concentration of ovarian tissue were lower than in CLP+Saline group (P<0.05). The light microscopic assesment revealed that ovarian tissue was protected, and inflammation and interstitial edema decreased in CLP+ NR group. The follicular damage findings were notably decreased in CLP+NR group in comparison with CLP+Saline group (P<0.05).
CONCLUSIONS: Our findings indicated that nicotinamide riboside diminished ovarian injury in sepsis via inhibition of tissue infiltration and incresing of endogenous antioxidant capacity. Nicotinamide Riboside administration may represent a new treatment approache for the prevention of sepsis induced ovarian injury.
Full text links
Related Resources
Trending Papers
Hemodynamic Support in Sepsis.Anesthesiology 2024 June 2
The New Challenge of Obesity - Obesity-Associated Nephropathy.Diabetes, Metabolic Syndrome and Obesity 2024
Advances in Clinical Cardiology 2023: A Summary of Key Clinical Trials.Advances in Therapy 2024 May 15
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 2024 April 5
Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review.Seminars in Nephrology 2024 May 15
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app